Anagrelide is a platelet-reducing agent used in the treatment of essential thrombocythemia, a condition characterized by excessive platelet production. It works by inhibiting megakaryocyte maturation in the bone marrow. This helps reduce the risk of blood clots and strokes in affected individuals. Side effects may include palpitations, fluid retention, and headaches.
Cleanchem is a trusted provider of premium pharmaceutical reference materials, specializing in Anagrelide and its associated compounds. Our catalog includes pharmacopeial and non-pharmacopeial Anagrelide impurities, metabolites, nitrosamine derivatives (N-NO compounds), and stable isotope-labeled products. These reference standards play a critical role in pharmaceutical R&D, supporting activities such as product formulation, ANDA and DMF submissions, quality assurance, analytical method development, and stability assessments.
All Anagrelide-related substances undergo comprehensive characterization and are delivered with complete Certificates of Analysis and supporting analytical documentation to ensure regulatory adherence. Upon request, we can offer EP/USP traceable standards. Our products are routinely re-evaluated to maintain consistent quality and performance.
English
Arabic
Chinese (Simplified)
French
Japanese
Portuguese
Russian
Spanish
